- Breaking News
- |
- Entertainment
- |
- Sports
- |
- Business
- |
- Politics
- |
- Science
- |
- Technology
- |
- Odd News
- |
- Health
- |
- Law
Diabetes

A healthy body paves the way to a healthy mind.
IOWA CITY, Iowa - Iowa safety Tyler Sash visited defensive coordinator Norm Parker in the hospital Monday, and all Parker wanted to talk about was football.
LONDON - British drug regulators say GlaxoSmithKline's controversial diabetes pill Avandia should be pulled from the U.K.

WASHINGTON - Federal health experts said Wednesday the much-debated diabetes pill Avandia increases the risk of heart attack compared to other diabetes drugs.
DIABETES DEBATE: The Food and Drug Administration is asking a panel of outside physicians to weigh in on the safety of Avandia, a former blockbuster drug that some experts believe increases heart risks.
More News
- Diabetes pill controversy shows rift in FDA ranks
- FDA review spotlights heart risk of diabetes pill
- Diabetics eye obesity surgery to tame blood sugar
- Sales of diabetes meds, tests, supplies
- Miss. looks to Iran for rural health care model
- FDA probes diabetes risk with prostate cancer meds
- Bret Michaels recovering in facility for diabetics
- Sanofi-Aventis, CureDM developing diabetes drug
- 1 in 10 Chinese adults are diabetics, study finds
- Studies: Intense treatment doesn't help diabetics
- Freeman back for Hoyas after diabetes diagnosis
- Georgetown's leading scorer Freeman has diabetes
- Coroner: Casey Johnson's death diabetes related
- Coroner: Casey Johnson's death diabetes related
- J&J, charity to start testing artificial pancreas
- Lilly licenses PDL type 1 diabetes drug candidate
- US survey shows southern counties most obese
- Earnings Preview: Bristol-Myers 3Q earnings report
- Abbott highlights stent results in diabetics
- Early flu season _ what you need to know